SCTX SEC Form 4 filings
Scribe Therapeutics, Inc. Latest Insider Trading Activity
Our insider trading activity tracker for Scribe Therapeutics, Inc. shows 8 total open-market insider transactions for SCTX over the past 86 days. The latest displayed record by transaction date reports 3 purchases by Aghazadeh Behzad (Scribe Therapeutics, Inc. Director, 10% Owner, Other, See Remarks) totaling 2,391,238 shares at a weighted-average price of $15.16 per share, with the latest transaction dated July 28, 2026. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.
Insider Trading For SCTX Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. SCTX | 2026-07-29 | 2026-07-27 | Scribe Therapeutics, Inc. | Gordon Carl L | Director | Buy | 1 | 1,000,000 | $15.00 | $15,000,000.00 | 74.14% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. SCTX | 2026-07-29 | 2026-07-27 | Scribe Therapeutics, Inc. | Orbimed Advisors Llc | Director | Buy | 1 | 1,000,000 | $15.00 | $15,000,000.00 | 74.14% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. SCTX | 2026-07-28 | 2026-07-28 | Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director, 10% Owner, Other, See Remarks | Buy | 3 | 2,391,238 | $15.16 | $36,259,761.25 | 25.99% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. SCTX | 2026-07-27 | 2026-07-23 | Scribe Therapeutics, Inc. | Lucas Svetlana | Chief Business Officer | Buy | 1 | 3,000 | $15.00 | $45,000.00 | 100.00% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. SCTX | 2026-07-27 | 2026-07-23 | Scribe Therapeutics, Inc. | Parrot David | Chief Financial Officer | Buy | 2 | 2,666 | $15.00 | $39,990.00 | 100.00% | View Filing |
⚠️ THE SAMPLE ABOVE IS DEFERRED BY 6 HOURS ⚠️
Start your 2-week, no-credit-card free trial today to receive get down to the second insider trading updates in this directory or email.
Pricing
Free Trial
10 trading daysExplore every Premium feature before you pay.
- Full platform access
- 10 trading days
- No credit card required
- 20 years of alert history
- Live alert directory updates
Standard Monthly
ScheduledScheduled alerts with complete trade context.
- Email and Telegram delivery
- Alert intervals from every sixty minutes to once daily
- Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
- Highlighted cluster transactions and SEC filing links
- Access to the alert directory hourly refreshes
Premium Monthly
RecommendedFastest alerts with ticker-level control.
- Everything in Standard
- Instant delivery detection-to-outbound time averages 3.00 seconds
- Alert intervals starting from one minute
- Real time alert directory updates